Zoetis | ZTS - Current Assets



Zoetis reported $5.92B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
Align Technology USD 2.45B 46.03M Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Charles River Laboratories USD 1.47B 36.5M Jun/2025
Dentsply International USD 1.97B 12M Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Henry Schein USD 4.24B 206M Jun/2025
Idexx Laboratories USD 1.36B 44.74M Jun/2025
Illumina USD 2.64B 32M Jun/2025
IQVIA Holdings USD 6.35B 434M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Laboratory Of America USD 4.09B 297.5M Jun/2025
Merck USD 37.07B 1.56B Jun/2025
Neogen USD 576.94M 25.22M May/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Quest Diagnostics USD 2.2B 123M Jun/2025
Sanofi 37.02B 7B Jun/2025
Sanofi 37.02B 5.57B Jun/2025
Zoetis USD 5.92B 46M Jun/2025